3.0.0
1092
2025-12-05T08:42:14Z
2025-12-05T08:42:14Z
House
H
HR
2023-02-17
118
https://www.congress.gov/bill/118th-congress/house-bill/1092
[Congressional Record Volume 169, Number 33 (Friday, February 17, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. MATSUI:H.R. 1092.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the United States ConstitutionThe single subject of this legislation is:To strengthen the use of patient-experience data within thebenefit-risk framework for approval of new drugs.[Page H856]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2023-02-24T16:33:22Z
  - Referred To
2023-02-17T15:07:00Z

- BENEFIT Act of 2023
118
526
S
2023-02-16
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  - Identical bill
CRS
- 2023-02-24
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-02-17
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2023-02-17
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-02-17
Introduced in House
IntroReferral
1000
9
Library of Congress
- M001163
Rep. Matsui, Doris O. [D-CA-7]
Doris
Matsui
D
CA
O.
7
N
- W000815
Rep. Wenstrup, Brad R. [R-OH-2]
Brad
Wenstrup
R
OH
R.
2
2023-02-17
True
- B001257
Rep. Bilirakis, Gus M. [R-FL-12]
Gus
Bilirakis
R
FL
M.
12
2023-03-21
False
- P000597
Rep. Pingree, Chellie [D-ME-1]
Chellie
Pingree
D
ME
1
2023-04-10
False
- Y000067
Rep. Yakym, Rudy [R-IN-2]
Rudy
Yakym
R
IN
2
2023-04-10
False
- G000590
Rep. Green, Mark E. [R-TN-7]
Mark
Green
R
TN
E.
7
2023-04-13
False
- R000305
Rep. Ross, Deborah K. [D-NC-2]
Deborah
Ross
D
NC
K.
2
2023-04-18
False
- B001309
Rep. Burchett, Tim [R-TN-2]
Tim
Burchett
R
TN
2
2023-04-19
False
- G000592
Rep. Golden, Jared F. [D-ME-2]
Jared
Golden
D
ME
F.
2
2023-05-02
False
- W000826
Rep. Wild, Susan [D-PA-7]
Susan
Wild
D
PA
7
2023-09-08
False
- B001298
Rep. Bacon, Don [R-NE-2]
Don
Bacon
R
NE
2
2023-09-08
False
- C001061
Rep. Cleaver, Emanuel [D-MO-5]
Emanuel
Cleaver
D
MO
5
2023-09-08
False
- C001097
Rep. Cárdenas, Tony [D-CA-29]
Tony
Cárdenas
D
CA
29
2023-09-26
False
- H001090
Rep. Harder, Josh [D-CA-9]
Josh
Harder
D
CA
9
2023-09-26
False
- F000466
Rep. Fitzpatrick, Brian K. [R-PA-1]
Brian
Fitzpatrick
R
PA
K.
1
2023-09-26
False
- T000488
Rep. Thanedar, Shri [D-MI-13]
Shri
Thanedar
D
MI
13
2023-10-10
False
- H001038
Rep. Higgins, Brian [D-NY-26]
Brian
Higgins
D
NY
26
2023-10-10
False
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2023-10-10
False
- P000616
Rep. Phillips, Dean [D-MN-3]
Dean
Phillips
D
MN
3
2023-10-12
False
- C001053
Rep. Cole, Tom [R-OK-4]
Tom
Cole
R
OK
4
2023-10-18
False
- G000583
Rep. Gottheimer, Josh [D-NJ-5]
Josh
Gottheimer
D
NJ
5
2023-10-30
False
- V000133
Rep. Van Drew, Jefferson [R-NJ-2]
Jefferson
Van Drew
R
NJ
2
2023-12-05
False
- G000582
Rescom. González-Colón, Jenniffer [R-PR-At Large]
Jenniffer
Gonzalez-Colon
R
PR
0
2023-12-22
False
- L000578
Rep. LaMalfa, Doug [R-CA-1]
Doug
LaMalfa
R
CA
1
2024-01-29
False
- L000599
Rep. Lawler, Michael [R-NY-17]
Michael
Lawler
R
NY
17
2024-03-07
False
- T000467
Rep. Thompson, Glenn [R-PA-15]
Glenn
Thompson
R
PA
15
2024-03-19
False
- J000307
Rep. James, John [R-MI-10]
John
James
R
MI
10
2024-03-19
False
- W000797
Rep. Wasserman Schultz, Debbie [D-FL-25]
Debbie
Wasserman Schultz
D
FL
25
2024-05-21
False
- T000469
Rep. Tonko, Paul [D-NY-20]
Paul
Tonko
D
NY
20
2024-05-22
False
- L000601
Rep. Landsman, Greg [D-OH-1]
Greg
Landsman
D
OH
1
2024-06-07
False
- B001306
Rep. Balderson, Troy [R-OH-12]
Troy
Balderson
R
OH
12
2024-06-26
False
- G000576
Rep. Grothman, Glenn [R-WI-6]
Glenn
Grothman
R
WI
6
2024-09-25
False
Health
Health
2023-03-15T20:15:17Z
00
2023-02-17
Introduced in House
2023-06-22T13:17:09Z
Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 or the BENEFIT Act of 2023
This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.
After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.

BENEFIT Act of 2023
- Display Title
45

BENEFIT Act of 2023
2024-07-24T15:23:37Z
- Short Title(s) as Introduced
101

BENEFIT Act of 2023
2024-05-24T13:42:10Z
Introduced in House
IH
- Short Title(s) as Introduced
101

Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023
2024-05-24T13:42:10Z
Introduced in House
IH
- Official Title as Introduced
6

To strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
2024-03-18T20:21:19Z
Introduced in House
IH
- Introduced in House
2023-02-17T05:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr1092ih/xml/BILLS-118hr1092ih.xml
2023-02-24
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.